TB Research

Recombinant AhpC antigen from Mycobacterium bovis boosts BCG-primed immunity in mice

Ozgun F. Duzenli, Sezer Okay, İnci Kazkayası, Filiz Öner

TURKISH JOURNAL OF BIOLOGY · 2021-01

Abstract

. Vaccine antigen AhpC was formulated with Montanide ISA 61 VG, an oil-based emulsion adjuvant. Both IgG and IL-12 responses were observed in mice after administering the formulation both as a subunit vaccine alone and also as a booster vaccine for BCG immunization. However, a long-lasting response was observed when AhpC formulation was used as a booster (for BCG-primed immunization) as compared to being used as a subunit vaccine alone. In short, these findings suggested that AhpC has the potential to be used as a booster vaccine candidate for BCG-primed immunization.

MeSH terms

  • Mycobacterium bovis
  • Immunization
  • Biology
  • Vaccination
  • Virology
  • Adjuvant
  • Booster dose
  • Antigen
  • BCG vaccine
  • Microbiology
  • Immunity
  • Tuberculosis vaccines
  • Recombinant DNA
  • Mycobacterium tuberculosis
  • Tuberculosis
  • Immune system